Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1996
05/15/1996EP0711343A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
05/15/1996EP0711301A1 Processes and intermediates for phosphorous-containing covalent linkages
05/15/1996EP0711297A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity
05/15/1996EP0711290A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711173A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
05/15/1996EP0711168A1 Methods of treating apoptosis and associated conditions
05/15/1996EP0711165A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996EP0711149A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use
05/15/1996EP0537168B1 Ctaa 28a32, the antigen recognized by mca 28a32
05/15/1996EP0479867B1 Compositions useful as contraceptives in males
05/15/1996EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy
05/15/1996EP0343217B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
05/15/1996CN1122600A Second messenger cell signaling inhibitors
05/15/1996CN1122329A Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
05/15/1996CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment
05/15/1996CN1122246A Snow Ganoderma lucidum oral liquid
05/15/1996CN1122245A Snow Ganoderma lucidum solid medicament
05/14/1996US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
05/14/1996US5516887 Luteinizing hormone releasing hormone antagonist peptides
05/14/1996US5516806 Ornithine decarboxylase inhibiting cyclic aminooxy compounds
05/14/1996US5516805 Antiischemic agents, anticarcinogenic agents and antiarrhythmia agents for cardiovascular disorders
05/14/1996US5516775 Further use of pyrimidine derivatives
05/14/1996US5516771 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
05/14/1996US5516754 Method for the selective dissolution of cancer cells using a composition derived from the photosynthetic system of plants and mammalian embryonic tissue
05/14/1996US5516658 DNA encoding cytokines that bind the cell surface receptor hek
05/14/1996US5516631 Method of inhibiting replication of hyperproliferative cells
05/14/1996CA2008632C Method of inducing the production of cytokines
05/14/1996CA1338325C Pharmaceutical composition and method of use
05/10/1996CA2162342A1 Intravenous solutions for a derivative of staurosporine
05/10/1996CA2162341A1 Pharmaceutical carriers
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013592A2 Protein kinase npk-110
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013512A2 L-ribofuranosyl nucleosides
05/09/1996WO1996013504A1 β,β'-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, BACTERIOCHLORINS, AND METHODS FOR MAKING THE SAME FROM β,β'-UNSUBSTITUTED TETRAPYRROLIC MACROCYCLES
05/09/1996WO1996013498A2 L-erythrosyl nucleosides
05/09/1996WO1996013495A1 Taxoid derivatives, their preparation and their use as antitumor agents
05/09/1996WO1996013494A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
05/09/1996WO1996013290A1 Device for aerosolized delivery of peptide drugs
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013259A2 Method and compositions for inhibiting protein kinases
05/09/1996WO1996013258A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide
05/09/1996WO1996010034A3 Thiol-free inhibitors of farnesyl-protein transferase
05/09/1996CA2203910A1 Novel protein kinase (npk-110)
05/09/1996CA2203757A1 Method and compositions for inhibiting protein kinases
05/09/1996CA2203257A1 Device for aerosolized delivery of peptide drugs
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2202682A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
05/08/1996EP0710722A1 Genetic mechanisms of tumor suppression
05/08/1996EP0710689A2 Polymeric antitumor agents
05/08/1996EP0710667A2 Modified oligonucleotides, their preparation and their use
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710240A1 Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus
05/08/1996EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710107A1 N,n,n-trimethylsphingosine derivatives
05/08/1996EP0593437B1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
05/08/1996EP0576669A4 Novel methods and compositions for treatment of angiogenic diseases
05/08/1996EP0328578B1 Antigen recognized by mca 16-88
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1122105A Treatment of tumors with compounds having RXR retinoid receptor agonist activity
05/08/1996CN1121832A Anticancer drug
05/08/1996CN1031754C Process for preparing dithiane
05/07/1996US5514794 Antibody-drug conjugates
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514711 Styrene derivatives
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514677 Hydroxamic acid based collagenase inhibitors
05/07/1996US5514664 Antitumor chemotherapy
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/05/1996CA2162075A1 Modified oligonucleotides, their preparation and their use
05/02/1996WO1996012791A1 Human abh
05/02/1996WO1996012728A1 L-pyranosyl nucleosides
05/02/1996WO1996012727A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
05/02/1996WO1996012503A1 Remedy for diseases caused by il-6 production
05/02/1996WO1996012497A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
05/02/1996WO1996003997A3 Treatment of cancer using hsv mutant
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996CA2161603A1 Polymeric antitumor agents
05/01/1996EP0709397A1 p53as Protein and antibody therefor
05/01/1996EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them
05/01/1996EP0709090A2 Compositions for treating resistant tumors
05/01/1996EP0708877A1 Method for repairing a combustion chamber assembly
05/01/1996EP0708829A1 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
05/01/1996EP0708785A1 Heparin derivatives having antimetastatic activity
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708751A1 Synthesis of combinatorial arrays of organic compounds through the use of multiple component combinatorial array syntheses
05/01/1996EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708655A1 Methods of using insulin-like growth factor binding proteins
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996EP0708642A1 Taxol derivatives
05/01/1996EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
05/01/1996EP0491031B1 Cdr grafted anti-cea antibodies and their production
1 ... 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 ... 2211